- Home
- BDTX
as 10-29-2025 9:36am EST
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | 181.4M | IPO Year: | 2020 |
| Target Price: | $10.40 | AVG Volume (30 days): | 919.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.20 - $4.45 | Next Earning Date: | 11-05-2025 |
| Revenue: | $70,000,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Black Diamond Therapeutics Inc. News
BDTX Breaking Stock News: Dive into BDTX Ticker-Specific Updates for Smart Investing
Zacks
7 days ago
BDTX vs. ORIC: Which Oncology Focused Biotech Stock Is a Better Pick Now?
Zacks
14 days ago
Can NSCLC Drug Silevertinib Drive Sustainable Growth for BDTX?
Simply Wall St.
18 days ago
Black Diamond Therapeutics (BDTX): Valuation Insights After Surging Interest From Strong Earnings and Growth Momentum
Zacks
20 days ago
BDTX Stock Hits 52 Week High: Is There More Room for Growth?
Zacks
20 days ago
Is Medpace (MEDP) Outperforming Other Medical Stocks This Year?
Zacks
22 days ago
Black Diamond Therapeutics, Inc. (BDTX) Hit a 52 Week High, Can the Run Continue?
Zacks
2 months ago
Is BDTX's Cash balance Enough to Successfully Develop Its NSCLC Drug?
Insider Monkey
3 months ago
Black Diamond Therapeutics, Inc. (BDTX) Rated Outperform as Lead Drug Shows Promise
Compare BDTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDTX Black Diamond Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.